Publications from SELECT

The following citations are of reports that have been published in the scientific literature concerning the Selenium and Vitamin E Cancer Prevention Trial (SELECT). The citations are listed in reverse chronological order.

2011 Publications

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

• Authors: EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, LM Minasian, LG Ford, HL Parnes, JM Gaziano, DD Karp, MM Lieber, PJ Walther, L Klotz, JK Parsons, JL Chin, AK Darke,  SM Lippman, GE Goodman; FL Meyskens, LH Baker.
• Journal: Journal of the American Medical Association 306(14):1549-1556, 2011.

Effect of vitamin E and selenium on F2-isoprostanes, a biomarker of oxidative stress

• Authors: KA Guertin, AR Kristal,KB Arnold, JJ Crowley, JA Hartline, PJ Goodman, CM Tangen, LM Minasian, SM Lippman, E Klein, PA Cassano. 
• Poster Presentation: North American Congress of Epidemiology 3rd Annual Meeting (June 21-24, 2011, Montreal, Canada).

Effect of vitamin E and selenium on rate of decline in FEV1: the respiratory ancillary study to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

• Authors: PA Cassano, KA Guertin, AR Kristal, KB Arnold, JJ Crowley, JA Hartline, PJ Goodman, CM Tangen, LM Minasian, SM Lippman, E Klein. 
• Poster Discussion: American Thoracic Society 2011 Annual Meeting.

A secure website for participant submission of follow-up data 

• Authors: JA Hartline, A Smith, K Anderson. 
• Oral Presentation: Society for Clinical Trials 2011 meeting.

The consent process for transitioning a large trial to centralized follow-up

• Authors: M Yee, JA Hartline, K Anderson. 
• Poster Presentation: American Society of Preventive Oncology Meeting 2011.

Study transition from local in-person follow-up to centralized follow-up by mail

• Authors: K Anderson, J Hartline, J Harris-Talley. 
• Poster Presentation: American Society of Preventive Oncology 2011 Annual Meeting.

2010 Publications

Impact of supplemental site grants to increase African American accrual for SELECT

• Authors: ED Cook, KB Arnold, JA Hermos, W McCaskill-Stevens, S Moody-Thomas, JL Probstfield, SJ Hamilton, RD Campbell, KB Anderson, LM Minasian. 
• Journal: Clinical Trials: Journal of the Society for Clinical Trials 7(1):90-99, 2010.  

A nutrient approach to prostate cancer prevention: the Selenium and Vitamin E Cancer Prevention trial (SELECT)

• Authors: BK Dunn, ES Richmond, LM Minasian, AM Ryan, LG Ford. 
• Journal: Nutrition and Cancer 62(7):896-918, 2010. 

Editorial Comment 

• Author: IM Thompson. 
• Journal: Urology 75(3):509-510, 2010. 

Impact of supplemental site grants to increase African American accrual for the selenium and vitamin E cancer prevention trial

• Authors: E Cook, K Arnold, J Hermos, W McCaskill-Stevens, S Moody-Thomas, J Probstfield,, S Hamilton, R Campbell, K Anderson, L Minasian. 
• Poster presentation: Society of Clinical Trials 2010 Annual Meeting.

Impact of supplemental site grants to increase African American accrual for the selenium and vitamin E cancer prevention trial 

• Authors: E Cook, K Arnold, J Hermos, W McCaskill-Stevens, S Moody-Thomas, J Probstfield, S Hamilton, R Campbell, K Anderson, L Minasian. 
• Poster presentation: NCI-ASCO meeting "Cancer Trial Accrual Symposium: Science and Solutions," Bethesda, MD, April 29-30, 2010.

Infrastructure for successful recruitment when conducting a multi-site clinical trial: the SELECT experience

• Authors: KB Anderson, ED Cook, SJ Hamilton, LM Minasian, JA Hermos, JL Probstfield. 
• Poster presentation: NCI-ASCO meeting “Cancer Trial Accrual Symposium: Science and Solutions," Bethesda, MD, April 29-30, 2010.

The role of a community based organization in a large prevention trial 

• Authors: SJ Hamilton, ED Cook, KB Anderson, JQ Sheats. 
• Poster presentation: NCI-ASCO meeting, "Cancer Trial Accrual Symposium: Science and Solutions," Bethesda, MD, April 29-30, 2010.

Effect of vitamin E and selenium on incidence of physician-diagnosed COPD: the selenium and vitamin E cancer prevention trial (SELECT) 

• Authors: PA Cassano, KB Arnold, K Guertin, AR Kristal, JJ Crowley JA Hartline, PJ Goodman,CM Tangen, LM Minasian, SM Lippman, CA Coltman, E Klein. 
• Oral presentation: American Thoracic Society 2010 Annual Meeting; American Journal of Respiratory and Critical Care Medicine 181:A6765, 2010.

Video productions in SELECT: effective tools for staff learning and participant motivation in clinical trials

• Authors: JM Harris-Talley, D Arney, K Anderson, JA Hartline. 
• Poster presentation: Society for Clinical Trials 2010 Meeting.

2009 Publications

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT)

• Authors: SM Lippman, EA Klein, PJ Goodman, MS Lucia, IM Thompson, LG Ford, HL Parnes, LM Minasian, JM Gaziano, JA Hartline, JK Parsons, JD Bearden, ED Crawford, GE Goodman, J Claudio, E Winquist, ED Cook, DD Karp, PJ Walther, MM Lieber, AR Kristal, A Darke, K Arnold, PA Ganz, RM Santella, D Albanes, PR Taylor, JL Probstfield,TJ Jagpal, JJ Crowley, FL Meyskens, LH Baker, CA Coltman. 
• Journal: Journal of the American Medical Association 301(1):39-51, 2009. 

The Selenium and Vitamin E Cancer Prevention Trial

• Author: EA Klein. 
• Publication: In, Prostate Cancer Screening, 2nd edition, D Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, NY, Chapter 25, pp. 349-360, 2009.

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial

• Authors: EA Platz, SM Lippman. 
• Journal: Journal of Clinical Oncology 27(22):3569-3572, 2009.  

Selenium and Vitamin E: Interesting biology and dashed hope

• Author: EA Klein. 
• Journal: Journal of the National Cancer Institute 101(5):283-285, 2009. 

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention 

• Authors: BK Dunn, A Ryan, LG Ford. 
• Journal: Recent Results in Cancer Research 181:183-193, 2009. 

Chemoprevention of prostate cancer

• Authors: IM Thompson, CM Tangen, PJ Goodman, MS Lucia, EA Klein. 
• Journal: Journal of Urology 182(2):499-507, 2009.  

The selenium and vitamin E cancer prevention trial (SELECT): Southwest Oncology Group Study S0000 

• Authors: EA Klein, SM Lippman, PJ Goodman, MS Lucia, IM Thompson, LG Ford, HL Parnes, LM Minasian, JM Gaziano, J Hartline. 
• Journal: 2009 American Society of Clinical Oncology Genitourinary Cancers Symposium, Feb. 26-28, 2009, abstr. #1.

Communicating the early end of intervention to participants in a large ongoing study

• Authors: J Hartline, E Cook, J Harris-Talley, K Weaver. 
• Poster presentation: American Society for Preventive Oncology Annual Meeting, March 8-10, 2009.

Moving to centralized follow-up from a site-based model in a large cancer prevention study

• Authors: P Goodman, J Hartline, E Klein. 
• Journal: Proceedings of AACR 2009 Frontiers in Cancer Prevention Research Conference, abst. #A85, p. 89, 2009.

Cancer prevention clinical trials: assessing for disparities in recruitment in Hawaii

• Authors: E Bantum, I Cheng, K Cassel L Ka’opua, J Berenberg. 
• Journal: AACR 2009 Proceedings of Frontiers in Cancer Prevention Research, abst. #B26, p.116, 2009.

2008 Publications

Bridging the gap between populations: the challenge of reducing cancer disparities among African Americans and other racial/ethnic minority populations 

• Authors: SD Williams-Brown, ED Cook, K Anderson, SJ Hamilton. 
• Journal: US Oncology 4(1):72-75, 2008. 

2007 Publications

Impact of new external research results in an ongoing trial

• Authors: AK Darke, JL Hartline, P. Goodman. 
• Journal: Journal of the Society for Clinical Trials, #144, p.115, 2007

2006 Publications

Local perspective of the impact of the HIPAA privacy rule on research

• Authors: MS Wolf , CL Bennett. 
• Journal: Cancer 106(2):474-479, 2006.  

Studying the effects of vitamin E and selenium for Alzheimer’s disease prevention: the PREADVISE model 

• Authors: AM Caban-Holt, FA Schmitt, CR Runyons, RJ Kryscio, MS Mendiondo, MS Healey, WR Markesbery, CA Coltman, JJ Crowley, PJ Goodman, JL Hartline. 
• Publication: In: Research and Practice In Alzheimer’s Disease Volume 11, 2006, B Vellas, LJ Fitten, B Winblad, H Feldman, M Grundman, E Giacobini eds., Serdi Publishers 124-130, 2006.
  

2005 Publications

Designing the selenium and vitamin E cancer prevention trial (SELECT)

• Authors: SM Lippman; PJ Goodman; EA Klein; HL Parnes; IM Thompson, Jr; AR Kristal; RM Santella; JL Probstfield; CM Moinpour; D Albanes; PR Taylor; LM Minasian; A Hoque; SM Thomas; JJ Crowley; JM Gaziano; JL Stanford; ED Cook; NE Fleshner; MM Lieber; PJ Walther; FR Khuri; DD Karp; GG Schwartz; LG Ford; CA Coltman, Jr.
• Journal: Journal of the National Cancer Institute 97(2):94-102. (2005).

Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones and lymphocyte viability 

• Authors: AR Kristal, IB King, D Albanes, MN Pollak, FZ Stanzyk, RM Santella, A Hoque. Cancer Epidemiology, Biomarkers & Prevention 14(3):727-730, 2005. PMID: 15767358
  Minority recruitment to the selenium and vitamin E cancer prevention trial (SELECT). ED Cook, SM Thomas, KB Anderson, R Campbell, SJ Hamilton, JM Harrington, SM Lippman, LM Minasian, ED Paskett, S Craine, KB Arnold, JL Probstfield. 
• Journal: Clinical Trials 2:436-442, 2005.  

Phase III prostate cancer prevention trials: are the costs justified? 

• Authors: IM Thompson,  CM Tangen, EA Klein, SM Lippman. 
• Journal: Journal of Clinical Oncology 23(32):8161-8164, 2005. PMID:

Study-provided resources for quality pill counts

• Author: KB Gower. 
• Journal: Clinical Trials 2(Suppl 1):S58 (#P29), 2005.

Supplemental financial support for minority recruitment: SELECT-selenium and vitamin E cancer prevention trial 

• Authors: KB Anderson, R Campbell, GB Gower, S Hamilton, W McCaskill-Stevens, L Minasian, SM Thomas, S Moon, F Stallings, J Probstfield. 
• Journal: Clinical Trials 2(Suppl 1):S57 (#P25), 2005.

Minority participant accrual workshops-innovative strategy to increase African American accrual 

• Author: RD Campbell. 
• Journal: Clinical Trials 2(Suppl 1):S81 (#P80), 2005.

Minority recruitment to the selenium and vitamin E cancer prevention trial (SELECT) 

• Authors: ED Cook, SM Thomas, KB Anderson, R Campbell, SJ Hamilton, JM Harrington, SM Lippman, LM Minasian, ED Paskett, S Craine, J Probstfield. 
• Journal: Clinical Trials 2(Suppl1):S82 (#P81), 2005.

The black church: an invaluable ally for enhancing minority recruitment 

• Authors: JM Harrington, S Hamilton, R Campbell, S Moon, E Cook. 
• Journal: Clinical Trials 2(Suppl 1):S24 (#05), 2005.

2004 Publications

Introducing HIPPAA: triple the cost and triple and time for patient recruitment to the SELECT study

• Authors: NS Gorby; MS Wolf; CL Bennett.
• Journal: Proc of the American Society of Clinical Oncology 23:519 (#6009). (2004).

Prostate cancer chemoprevention: an overview of United States trials

• Authors: A Barqawi; IM Thompson; ED Crawford.
• Journal: Journal of Urology 171:S5-S9. (2004).

Participant’s perception of recruitment and retention in the selenium and vitamin E cancer prevention trial 

• Authors: D Banerjee, JM Choe, D Ward, AM Hoque, K Basen-Engquist, J Song, D Ramsey, SM Lippman, ED Cook. 
• Journal: Proc of AACR Frontiers in Cancer Prevention Research, Oct 16-20:131, 2004.

2003 Publications

Challenges of implementing ancillary studies within multi-site clinical trials

• Authors: T Chay; P Goodman; J Hartline.
• Journal: Controlled Clinical Trials 24(3S)Suppl:182S(#P173). (2003).

Drug distribution challenges in a multi-site clinical trial

• Authors: A Darke; J Vertrees; P Goodman.
• Journal: Controlled Clinical Trials 24(3S)Suppl:203S(#P217). (2003).

Effectiveness of a media-based launch to recruit to a prostate cancer prevention trial

• Authors: L Minasian; K Smigel-Croker; A Ryan; A Voss; L Cave; E Klein; L Ford.
• Journal: Controlled Clinical Trials 24(3S)Suppl:50S (#14). (2003).

Form and function: PDF+ versus HTML form design

• Authors: K Gower; B Kleinman.
• Journal: Controlled Clinical Trials 24(3S)Suppl:188A(#P186). (2003).

Optimizing data collection in a large web-based trial

• Authors: KB Gower; A Darke.
• Journal: Controlled Clinical Trials 24(3S):47S(#10). (2003).

Planning for successful recruitment for cancer trials

• Authors: K Anderson; J Probstfield; SM Thomas.
• Journal: Controlled Clinical Trials 24(3S)Suppl:102S(#P18). (2003).

2002 Publications

The challenges and benefits of a web-based trial

• Authors: B Kleinman; A Darke; JA Hartline.
• Journal: Controlled Clinical Trials 23(2S):91S-92S(#P.62). (2002).

The Das/Kaplan article reviewed: The role of PC-SPES, selenium, and Vitamin E in prostate cancer

• Author: EJ SMall.
• Journal: Oncology 16(3):291-300. (2002).

2001 Publications

Molecular epidemiologic studies within the selenium and vitamin E cancer prevention trial (SELECT)

• Authors: A Hoque; D Albanes; SM Lippman; MR Spitz; PR Taylor; EA Klein; IM Thompson; P Goodman; JL Stanford; JJ Crowley; CA Coltman; RM Santella.
• Journal: Cancer Causes and Control 12:627-633. (2001).

SELECT: The next prostate cancer prevention trial

• Authors: EA Klein; IM Thompson; SM Lippman; PJ Goodman; D Albanes; PR Taylor; C Coltman.
• Journal: Journal of Urology 166:1311-1315. (2001).

The web-based management of the selenium and vitamin E cancer prevention trial

• Authors: PA Shaw; PJ Goodman; J Brace.
• Journal: Controlled Clinical Trials 22(2S):57S(#P06). (2001).

2000 Publications

SELECT: The selenium and vitamin E cancer prevention trial: rationale and design

• Authors: EA Klein; IM Thomposn; S Lippman; P Goodman; D Albanes; PR Taylor; C Coltman.
• Journal: Prostate Cancer and Prostatic Diseases 3:145-151. (2000).